Planning notice · Find a Tender
Next Generation Sequencing Testing (NGS)
Part of Next Generation Sequencing Testing (NGS).
NHS Blood and Transplant (NHSBT) are seeking a provider for Next Generation Sequencing (NGS) QC testing requirements for the Cellular and Molecular Therapies (CMT) directorate, namely the Clinical Biotechnology Centre (CBC). CBC handle a number of products in the production of Advanced Therapeutic Investigational Medicinal Products (ATMPs) and starter material master cell banks (MCBs). These require NGS QC testing services that meet specific regulatory requirements.
- Procurement
- Next Generation Sequencing Testing (NGS)
- Published
- 15 May 2025
- Status
- planning
- CPV
- —
- Tender period
- —
Other notices in this procurement
FAQs about this notice
What type of notice is this?
This is a planning notice published via Find a Tender on 15 May 2025.
Which procurement does this notice belong to?
It is part of "Next Generation Sequencing Testing (NGS)", published by NHS Blood and Transplant.
Get the full procurement picture
Enable turns the UK's public-contract data into pipeline intelligence for bid and capture teams. Talk to us about access, alerts and tailored market analysis.
Get in touch with Enable